Innovation & intellectual property · 16/06/2006Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Atamestane Patent
Summary
The U.S. Patent and Trademark Office has issued a certificate for a third one-year extension of the term of U.S. Patent No. 4,591,585, which covers atamestane, a medication used to treat certain medical conditions.
Original source language: Federal Register — Patent and Trademark OfficeOpen original release →